Guner Sebnem Izmr, Karacetin Didem, Yuksel Mahmut
Private Medicalpark Bahcelievler Hospital, Department of Hematology, Istanbul, Turkey.
Istanbul Research and Training Hospital, Radiation Oncology Department, Istanbul, Turkey.
World J Oncol. 2013 Feb;4(1):61-65. doi: 10.4021/wjon629w. Epub 2013 Mar 6.
Testicular lymphoma was first reported by Malassez and Curling in 1866. Primary testicular lymphoma constitutes only 1-7% of all testicular neoplasms and less than 1% of all non Hodgkin lymphoma. We report the case of a 47-year-old man without a particular past medical history, who presented with a painful left testicular swelling that he has noticed for several weeks. Radiological findings consisted in multiple hypoechoic masses that corresponded in histological examination to a diffuse intratubular lymphomatous infiltration situated away from the spermatic cord, the epididymis, ductuli efferentes and rete testis. Immunohistochemical study showed positivity of MUM-1, Bcl-2 and B-cell marker (CD20) and TdT, CD 3, CD5, Bcl-1, CD10, Bcl-6 and Myeloperoksidaz were negative. Ki-67 proliferation index was 90% of neoplastic lenfoid infiltration. The patient underwent full staging for lymphoma by positron emission tomography, showing right superior paratrakeal, precarinal, subcarinal, left paraaortic and retrocrural and left iliac involvement lymph nodes also the right testis and of extra-testicular involvement by the skeleton sistem. The diagnosis of stage III primary testicular large B-cell lymphoma of germinal center B-cell-like group was made. The patient is now treated by chemotherapy. Primary testicular lymphoma is a rare tumor whose diagnosis is based on histological findings. There are non consensual etiological or predisposing factors. Treatment modalities consist in surgical excision, chemotherapy and radiation therapy but the accurate procedures are not standardized. Factors that have been linked to more favorable outcomes include younger patient age, localized disease, presence of sclerosis at pathologic analysis, smaller tumor size, lower histological tumor grade and lack of epididymal or spermatic cord involvement.
睾丸淋巴瘤于1866年由马拉塞和柯林首次报道。原发性睾丸淋巴瘤仅占所有睾丸肿瘤的1 - 7%,占所有非霍奇金淋巴瘤的比例不到1%。我们报告一例47岁男性病例,该患者无特殊既往病史,数周来出现左侧睾丸疼痛性肿大。影像学检查发现多个低回声肿块,组织学检查显示为弥漫性小管内淋巴瘤浸润,远离精索、附睾、输出小管和睾丸网。免疫组化研究显示MUM - 1、Bcl - 2和B细胞标志物(CD20)呈阳性,而TdT、CD3、CD5、Bcl - 1、CD10、Bcl - 6和髓过氧化物酶呈阴性。Ki - 67增殖指数为肿瘤性淋巴样浸润的90%。患者通过正电子发射断层扫描进行淋巴瘤全面分期,显示右上气管旁、隆突前、隆突下、左主动脉旁、膈脚后和左髂淋巴结受累,右侧睾丸及骨骼系统存在睾丸外受累。诊断为生发中心B细胞样组III期原发性睾丸大B细胞淋巴瘤。该患者目前正在接受化疗。原发性睾丸淋巴瘤是一种罕见肿瘤,其诊断基于组织学检查结果。病因或易感因素尚无共识。治疗方式包括手术切除、化疗和放疗,但具体程序尚未标准化。与更有利预后相关的因素包括患者年龄较轻、疾病局限、病理分析存在硬化、肿瘤体积较小、组织学肿瘤分级较低以及无附睾或精索受累。